Financial News
MGC Pharmaceuticals' proprietary ZAM app "about good practice"
March 27, 2023 at 03:00 AM EDT
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner after announcing the enrolment of the first patient in its proprietary data collection App and machine learning algorithm, ZAM.
Clements explains why MGC is investing in medical technology, saying that "this is about good practice."
Contact Details
Proactive UK Ltd
+44 20 7989 0813
Report this content
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this articleMore News
View More
Enghouse Systems Q3 Earnings Call Highlights ↗
Today 11:02 EDT
This AI ETF Is Missing the Biggest AI Winners ↗
Today 10:20 EDT
Kroger Q2 Earnings Call Highlights ↗
Today 10:03 EDT
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
